Search results for "Coronavirus"
New research adds to data on symptoms after COVID-19, vaccines' effects
Several COVID-19 studies looked at persistent symptoms, while new vaccine research found limited antibody responses in some patients and advised on tests for clotting complications. Other studies quantified the target population for tocilizumab treatment and gender differences in infections.
https://immattersacp.org/weekly/archives/2021/05/25/1.htm
25 May 2021
Psychological, disparate effects of the pandemic detailed by recent research
Mental health problems were prevalent among U.S. adults in June, obesity is strongly associated with mortality from COVID-19, and an inactivated vaccine has shown promise in a phase 1/2 Chinese trial.
https://immattersacp.org/weekly/archives/2020/08/18/1.htm
18 Aug 2020
Effects of pandemic on alcohol use, mental health, primary care, and hospitalizations
Recent studies found that the pandemic was associated with increases in alcohol use and internet searches for mental health issues. The rise of telemedicine meant fewer blood pressure and cholesterol evaluations, and hospitalizations for several non-COVID-19 conditions stayed below normal.
https://immattersacp.org/weekly/archives/2020/10/06/1.htm
6 Oct 2020
Latest research on COVID-19 antibodies, cardiac and stroke risks, mortality rates
A monoclonal antibody treatment showed benefit in outpatients, data varied on duration of antibody response, cardiac effects appeared common while strokes were not, and mortality improved, among other recent findings on COVID-19.
https://immattersacp.org/weekly/archives/2020/11/03/1.htm
3 Nov 2020
Treatment for high-risk COVID-19 patients, vaccine news, research on health messaging
An industry-funded study found benefit with bamlanivimab plus etesevimab for high-risk ambulatory COVID-19 patients, the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine, and two studies looked at COVID-19 messaging for minority populations.
https://immattersacp.org/weekly/archives/2021/07/20/1.htm
20 Jul 2021
New research analyzes COVID-19 outcomes, testing, and experimental treatments
A retrospective report looked at serologic antibody testing, while two case series reports described use of convalescent plasma in critically ill patients with COVID-19 in China.
https://immattersacp.org/weekly/archives/2020/04/07/2.htm
7 Apr 2020
Many recent studies reporting on COVID-19 vaccines' safety, effectiveness
New studies looked at the safety of the adenovirus COVID-19 vaccines, the effectiveness of almost all the vaccines, and the impacts of COVID-19 infection in pregnancy and on long-term cardiac function. A physician columnist addressed pandemic-related anger.
https://immattersacp.org/weekly/archives/2021/05/11/1.htm
11 May 2021
COVID-19 research focuses on at-home testing, steroids, hydroxychloroquine, zinc
At-home testing worked, steroids' effects varied by C-reactive protein level, and hydroxychloroquine and zinc were ineffective for COVID-19, according to newly published studies.
https://immattersacp.org/weekly/archives/2020/07/28/1.htm
28 Jul 2020
Latest recommendations reject hydroxychloroquine, support remdesivir
Both ACP and The BMJ completed evidence reviews and issued recommendations on use of certain drugs for COVID-19. Another article warned about Strongyloides hyperinfection, a potentially dangerous side effect of dexamethasone for some patients.
https://immattersacp.org/weekly/archives/2020/08/04/1.htm
4 Aug 2020
New guidelines on COVID-19 antibody testing, flu vaccination and trial data on remdesivir
Infectious diseases experts offered guidance on the use of antibody tests in practice, a remdesivir trial showed disappointing results, the CDC recommended flu vaccination for people six months and up, and a study reported post-ICU outcomes of patients with COVID-19.
https://immattersacp.org/weekly/archives/2020/08/25/1.htm
25 Aug 2020